142 related articles for article (PubMed ID: 7525096)
21. [Relationship between the expression of the genes encoding the key enzymes for cytarabine metabolism and the pharmacokinetics of cytarabine in the treatment of childhood acute leukemia with high-dose cytarabine].
Xie XT; Jiang SY; Li BS; Yang LL
Zhonghua Er Ke Za Zhi; 2008 Apr; 46(4):276-80. PubMed ID: 19099730
[TBL] [Abstract][Full Text] [Related]
22. Biochemical interactions between methotrexate and 1-beta-D-arabinofuranosylcytosine in hematopoietic cells of children: a Pediatric Oncology Group study.
Newman EM; Villacorte DG; Testi AM; Krance RA; Harris MB; Ravindranath Y; Pinkel D
Cancer Chemother Pharmacol; 1990; 27(1):60-6. PubMed ID: 2245494
[TBL] [Abstract][Full Text] [Related]
23. Modulation of intracellular metabolism of cytosine arabinoside in acute myeloid leukemia by granulocyte-macrophage colony-stimulating factor.
Reuter C; Auf der Landwehr U; Schleyer E; Zühlsdorf M; Ameling C; Rolf C; Wörmann B; Büchner T; Hiddemann W
Leukemia; 1994 Feb; 8(2):217-25. PubMed ID: 8309245
[TBL] [Abstract][Full Text] [Related]
24. Role of deoxycytidine kinase in the inhibitory activity of 5-substituted 2'-deoxycytidines and cytosine arabinosides on tumor cell growth.
Balzarini J; De Clercq E
Mol Pharmacol; 1983 Jan; 23(1):175-81. PubMed ID: 6306422
[TBL] [Abstract][Full Text] [Related]
25. Imbalanced DNA synthesis induced by cytosine arabinoside and fludarabine in human leukemia cells.
Carbone GM; Catapano CV; Fernandes DJ
Biochem Pharmacol; 2001 Jul; 62(1):101-10. PubMed ID: 11377401
[TBL] [Abstract][Full Text] [Related]
26. Metabolism of 4'-thio-beta-D-arabinofuranosylcytosine in CEM cells.
Parker WB; Shaddix SC; Rose LM; Waud WR; Shewach DS; Tiwari KN; Secrist JA
Biochem Pharmacol; 2000 Dec; 60(12):1925-32. PubMed ID: 11108809
[TBL] [Abstract][Full Text] [Related]
27. Effect of UVC and araC on L5178Y-R and L5178Y-S cells. Nucleoid sedimentation.
Walicka M; Godlewska E; Kleczkowska H
Acta Biochim Pol; 1987; 34(4):345-55. PubMed ID: 3450097
[TBL] [Abstract][Full Text] [Related]
28. Biotransformation and in vitro activity of an arabinosylcytosine 5'-chloro-5'-deoxy analog.
Novotný L; Reichelová V; Balázová E; Scheithauer W; Benesová M; Ujházy V
Anticancer Drugs; 1991 Oct; 2(5):495-502. PubMed ID: 1804392
[TBL] [Abstract][Full Text] [Related]
29. Qualitative differences between replicative and repair synthesis of DNA in normal and transformed mouse cells as measured by precursor discrimination.
Elliott GC; Downes CS
Mutat Res; 1986 Nov; 166(3):295-302. PubMed ID: 3097531
[TBL] [Abstract][Full Text] [Related]
30. Sequential combination of methotrexate and 1-beta-D-arabinofuranosylcytosine shows synergistic effect on the generation of DNA strand breaks in a human promyelocytic leukemia cell line.
Tanizawa A; Kubota M; Takimoto T; Kito T; Akiyama Y; Kiriyama Y; Mikawa H
Adv Exp Med Biol; 1989; 253B():349-54. PubMed ID: 2610122
[No Abstract] [Full Text] [Related]
31. Potentiation of the activity of 1-beta-D-arabinofuranosylcytosine by the protein kinase C activator bryostatin 1 in HL-60 cells: association with enhanced fragmentation of mature DNA.
Grant S; Jarvis WD; Swerdlow PS; Turner AJ; Traylor RS; Wallace HJ; Lin PS; Pettit GR; Gewirtz DA
Cancer Res; 1992 Nov; 52(22):6270-8. PubMed ID: 1423273
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of cis-diammine-1,1-cyclobutane dicarboxylatoplatinum(II)-induced DNA interstand cross-link removal and potentiation of cis-diammine-1,1-cyclobutane dicarboxylatoplatinum(II) cytotoxicity by hydroxyurea and 1-beta-D-arabinofuranosylcytosine.
Swinnen LJ; Ellis NK; Erickson LC
Cancer Res; 1991 Apr; 51(8):1984-9. PubMed ID: 2009517
[TBL] [Abstract][Full Text] [Related]
33. 2-Chloro-2'-deoxyadenosine inhibits DNA repair synthesis and potentiates UVC cytotoxicity in chronic lymphocytic leukemia B lymphocytes.
Van Den Neste E; Cardoen S; Husson B; Rosier JF; Delacauw A; Ferrant A; Van den Berghe G; Bontemps F
Leukemia; 2002 Jan; 16(1):36-43. PubMed ID: 11840261
[TBL] [Abstract][Full Text] [Related]
34. Structural basis for polymerase η-promoted resistance to the anticancer nucleoside analog cytarabine.
Rechkoblit O; Choudhury JR; Buku A; Prakash L; Prakash S; Aggarwal AK
Sci Rep; 2018 Aug; 8(1):12702. PubMed ID: 30140014
[TBL] [Abstract][Full Text] [Related]
35. 1-beta-D-arabinofuranosylcytosine and hydroxyurea production of cytotoxic synergy with cis-diamminedichloroplatinum(II) and modification of platinum-induced DNA interstrand cross-linking.
Swinnen LJ; Barnes DM; Fisher SG; Albain KS; Fisher RI; Erickson LC
Cancer Res; 1989 Mar; 49(6):1383-9. PubMed ID: 2924295
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of the antineoplastic activity of adozelesin alone and in combination with 5-aza-2'-deoxycytidine and cytosine arabinoside on DLD-1 human colon carcinoma cells.
Côté S; Momparler RL
Anticancer Drugs; 1993 Jun; 4(3):327-33. PubMed ID: 7689364
[TBL] [Abstract][Full Text] [Related]
37. Comparison of some biochemical parameters of arabinosylcytosine and cyclocytidine in L1210 murine leukemia cells.
Novotný L; Reichelová V; Balázová E; Ujházy V
Neoplasma; 1990; 37(1):13-22. PubMed ID: 1690864
[TBL] [Abstract][Full Text] [Related]
38. Cytotoxic synergy of cisplatin with concurrent hydroxyurea and cytarabine: summary of an in vitro model and initial clinical pilot experience.
Albain KS; Swinnen LJ; Erickson LC; Stiff PJ; Fisher SG; Fisher RI
Semin Oncol; 1992 Jun; 19(3 Suppl 9):102-9. PubMed ID: 1641650
[TBL] [Abstract][Full Text] [Related]
39. Aphidicolin and 1-beta-D-arabinofuranosylcytosine strongly inhibit transcriptionally active DNA repair in normal human fibroblasts.
Mirzayans R; Dietrich K; Paterson MC
Carcinogenesis; 1993 Dec; 14(12):2621-6. PubMed ID: 8269635
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of ribonucleotide reductase by a new class of isoindole derivatives: drug synergism with cytarabine (Ara-C) and induction of cellular apoptosis.
Nandy P; Lien EJ; Avramis VI
Anticancer Res; 1999; 19(3A):1625-33. PubMed ID: 10470093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
